THERAPEUTIC USES OF EMPAGLIFLOZIN

• 收藏
• 分享

专利权人:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

发明人:

ULI, BROEDL,MAXIMILIAN VON, EYNATTEN,SREERAJ, MACHA,HANS-JUERGEN, WOERLE

申请号：

TR201901110

公开号：

TR201901110T4

申请日:

2014.04.03

申请国别(地区):

TR

年份:

2019

代理人:

摘要：

The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellitus or pre-diabetes, in patients with renal impairment or chronic kidney disease (CKD).Mevcut buluş, böbrek hasarı veya kronik böbrek hastalığı (KBH) olan hastalarda tip 1 veya tip 2 diabetes mellitus veya prediyabet gibi metabolik bozuklukların tedavisi ve/veya önlenmesi için belirli SGLT-2 inhibitörleri ile ilgilidir.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/